APA (7th ed.) Citation

CH, H., JY, C., HY, C., WZ, H., YW, J., CY, L., . . . KC, H. (2026). Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapse. Cancer immunology, immunotherapy : CII, 75(3), . https://doi.org/10.1007/s00262-026-04336-9

Chicago Style (17th ed.) Citation

CH, Huang, et al. "Heterologous Prime-boost Immunization of AAV-based Neoantigen Cancer Vaccine Induces Anti-tumor Immunity to Inhibit Tumor Growth and Relapse." Cancer Immunology, Immunotherapy : CII 75, no. 3 (2026). https://doi.org/10.1007/s00262-026-04336-9.

MLA (9th ed.) Citation

CH, Huang, et al. "Heterologous Prime-boost Immunization of AAV-based Neoantigen Cancer Vaccine Induces Anti-tumor Immunity to Inhibit Tumor Growth and Relapse." Cancer Immunology, Immunotherapy : CII, vol. 75, no. 3, 2026, https://doi.org/10.1007/s00262-026-04336-9.